PPI in the Joint Funding Scheme

PPI is integrated throughout the Joint Funding Scheme. There are specific questions set out in the application form on PPI. In addition, at the Review Panel meeting, PPI is reviewed in the applications and a PPI rating contributes to the consensus panel score. It is therefore important to think about PPI from the very start of planning a research project and submitting an application to the Joint Funding Scheme.

HRCI has produced three case studies of PPI excellence in Joint Funding Scheme applications. The case studies outline the PPI plans and activities the applicants had laid out.  You can read them below and we thank the applicants and the HRCI members that they submitted their proposals to, for allowing us to share their excellent plans.

You might also be interested in

ERDERA marked the close of its second year with an Open Session on ultra-rare diseases, bringing together European, regulatory and scientific perspectives on how innovation can reach patients.
The Joint Transnational Call is expected to open on 1 December 2026, with an information webinar planned for 14 December.
Established in 2012, the EURORDIS Black Pearl Awards recognise contributions across the rare disease community. The programme will return to Brussels and online on 15 February 2027.
EURORDIS’ European Blueprint proposes 18 priority actions across six areas, offering a community-led foundation for a future EU Action Plan on Rare Diseases.